BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Other News

Orexigen Therapeutics Inc endocrine news

Orexigen reduced headcount by 23 (40%) to save cash after a complete response letter from FDA earlier this month for obesity candidate Contrave. In the letter, the agency requested the...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >